Yu Na Kang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yu Na Kang has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Byoung Kuk Jang
Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Republic of Korea
6 shared publications - Keun-Gyu Park
Department of Biomedical Science, Kyungpook National University, Daegu, South Korea
4 shared publications Hye Ra Jung
Department of Pathology, Keimyung University School of Medicine, Daegu, Korea
3 shared publicationsJae Seok Hwang
3 shared publications- Jin Bok Hwang
Department of Pediatrics, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea
3 shared publications - Eui-Cheol Shin
Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea
2 shared publications
Latest Publications
- Open Access
Src Inhibition Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation and Decreasing Connective Tissue Growth Factor
The SRC kinase family comprises non-receptor tyrosine kinases that are ubiquitously expressed in all cell types. Although Src is reportedly activated in pulmonary and renal fibrosis, little is known regarding its role in liver fibrosis. This study investigated whether the inhibition of Src protects against liver fibrosis. The expression of Src was upregulated in thioacetamide (TAA)-induced fibrotic mouse liver and cirrhosis of patients, and phospho-Src was upregulated during activation of hepatic stellate cells (HSC). In addition, Src inhibition reduced the expression of α-smooth muscle actin (αSMA) in primary HSCs and suppressed transforming growth factor β (TGF-β)-induced expression of connective tissue growth factor (CTGF) in hepatocytes. Src inhibitor Saracatinib also attenuated TAA-induced expression of type I collagen, αSMA, and CTGF in mouse liver tissues. The antifibrotic effect of Src inhibitors was associated with the downregulation of Smad3, but not of signal transducer and activator of transcription 3 (STAT3). In addition, Src inhibition increased autophagy flux and protected against liver fibrosis. These results suggest that Src plays an important role in liver fibrosis and that Src inhibitors could be treat liver fibrosis.
Open AccessSrc Inhibition Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation and Decreasing Connective Tissue Growth Factor
The SRC kinase family comprises non-receptor tyrosine kinases that are ubiquitously expressed in all cell types. Although Src is reportedly activated in pulmonary and renal fibrosis, little is known regarding its role in liver fibrosis. This study investigated whether the inhibition of Src protects against liver fibrosis. The expression of Src was upregulated in thioacetamide (TAA)-induced fibrotic mouse liver and cirrhosis of patients, and phospho-Src was upregulated during activation of hepatic stellate cells (HSC). In addition, Src inhibition reduced the expression of α-smooth muscle actin (αSMA) in primary HSCs and suppressed transforming growth factor β (TGF-β)-induced expression of connective tissue growth factor (CTGF) in hepatocytes. Src inhibitor Saracatinib also attenuated TAA-induced expression of type I collagen, αSMA, and CTGF in mouse liver tissues. The antifibrotic effect of Src inhibitors was associated with the downregulation of Smad3, but not of signal transducer and activator of transcription 3 (STAT3). In addition, Src inhibition increased autophagy flux and protected against liver fibrosis. These results suggest that Src plays an important role in liver fibrosis and that Src inhibitors could be treat liver fibrosis.
- Open Access
Clusterin Attenuates Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Downregulating the Smad3 Signaling Pathway
Clusterin is a glycoprotein that is expressed in most human tissues and found in body fluids. In our previous studies we demonstrated that clusterin has a protective effect against hepatic lipid accumulation and renal fibrosis; however, the role of clusterin in hepatic fibrosis is unknown. Here, we examined whether clusterin had protective effects against hepatic fibrosis using in vitro and in vivo models. Clusterin was upregulated in the livers of human cirrhotic patients and in thioacetamide (TAA)-induced and bile duct ligation mouse models of liver fibrosis. Loss and overexpression of clusterin promoted and attenuated hepatic fibrosis after TAA injection, respectively. In addition, we found that clusterin attenuates hepatic fibrosis by inhibiting the activation of hepatic stellate cells and Smad3 signaling pathways. Thus, clusterin plays an important role in hepatic fibrosis.
Open AccessClusterin Attenuates Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Downregulating the Smad3 Signaling Pathway
Clusterin is a glycoprotein that is expressed in most human tissues and found in body fluids. In our previous studies we demonstrated that clusterin has a protective effect against hepatic lipid accumulation and renal fibrosis; however, the role of clusterin in hepatic fibrosis is unknown. Here, we examined whether clusterin had protective effects against hepatic fibrosis using in vitro and in vivo models. Clusterin was upregulated in the livers of human cirrhotic patients and in thioacetamide (TAA)-induced and bile duct ligation mouse models of liver fibrosis. Loss and overexpression of clusterin promoted and attenuated hepatic fibrosis after TAA injection, respectively. In addition, we found that clusterin attenuates hepatic fibrosis by inhibiting the activation of hepatic stellate cells and Smad3 signaling pathways. Thus, clusterin plays an important role in hepatic fibrosis.
- Open Access
- 15 September 2018
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 52 (5) , 339-343
Bile Granuloma Mimicking Peritoneal Seeding: A Case Report
Laparoscopic cholecystectomy is a widely used treatment method for most cholelithiasis and is a relatively safe procedure. Foreign body granulomatous reaction to bile or gallstone spillage during laparoscopic cholecystectomy has rarely been reported. We report a case of bile granuloma after laparoscopic cholecystectomy, which mimicked peritoneal seeding. A 59-year-old Korean man presented with right upper quadrant pain. He underwent laparoscopic cholecystectomy for acute cholecystitis with cholelithiasis. Pathologic examination revealed an incidental adenocarcinoma invading the lamina propria with acute cholecystitis and cholelithiasis. After 3 months, follow-up abdominal computed tomography revealed a subhepatic nodule, which showed hypermetabolism on positron emission tomography-computed tomography. Suspecting localized peritoneal seeding, wedge resection of the liver, wedge resection of the transverse colon, and omentectomy were performed. Pathologic examination of the resected specimens revealed multiple bile granulomas. Awareness of bile granuloma mimicking malignancy is noteworthy for patient management to reduce unnecessary procedure during postoperative surveillance.
- 15 September 2018
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 52 (5) , 339-343
Open AccessBile Granuloma Mimicking Peritoneal Seeding: A Case Report
Laparoscopic cholecystectomy is a widely used treatment method for most cholelithiasis and is a relatively safe procedure. Foreign body granulomatous reaction to bile or gallstone spillage during laparoscopic cholecystectomy has rarely been reported. We report a case of bile granuloma after laparoscopic cholecystectomy, which mimicked peritoneal seeding. A 59-year-old Korean man presented with right upper quadrant pain. He underwent laparoscopic cholecystectomy for acute cholecystitis with cholelithiasis. Pathologic examination revealed an incidental adenocarcinoma invading the lamina propria with acute cholecystitis and cholelithiasis. After 3 months, follow-up abdominal computed tomography revealed a subhepatic nodule, which showed hypermetabolism on positron emission tomography-computed tomography. Suspecting localized peritoneal seeding, wedge resection of the liver, wedge resection of the transverse colon, and omentectomy were performed. Pathologic examination of the resected specimens revealed multiple bile granulomas. Awareness of bile granuloma mimicking malignancy is noteworthy for patient management to reduce unnecessary procedure during postoperative surveillance.
- 1 July 2018
- Published by Elsevier in Pathology - Research and Practice
- Vol. 214 (7) , 1031-1039
Tumorigenic role of YAP in hepatocellular carcinogenesis is involved in SHP2 whose function is different in vitro and in vivo
- 1 July 2018
- Published by Elsevier in Pathology - Research and Practice
- Vol. 214 (7) , 1031-1039
Tumorigenic role of YAP in hepatocellular carcinogenesis is involved in SHP2 whose function is different in vitro and in vivo
- Open Access
- 29 July 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 30846
Pyruvate dehydrogenase kinase regulates hepatitis C virus replication
During replication, hepatitis C virus (HCV) utilizes macromolecules produced by its host cell. This process requires host cellular metabolic reprogramming to favor elevated levels of aerobic glycolysis. Therefore, we evaluated whether pyruvate dehydrogenase kinase (PDK), a mitochondrial enzyme that promotes aerobic glycolysis, can regulate HCV replication. Levels of c-Myc, hypoxia-inducible factor-1α (HIF-1α), PDK1, PDK3, glucokinase, and serine biosynthetic enzymes were compared between HCV-infected and uninfected human liver and Huh-7.5 cells infected with or without HCV. Protein and mRNA expression of c-Myc, HIF-1α, and glycolytic enzymes were significantly higher in HCV-infected human liver and hepatocytes than in uninfected controls. This increase was accompanied by upregulation of serine biosynthetic enzymes, suggesting cellular metabolism was altered toward facilitated nucleotide synthesis essential for HCV replication. JQ1, a c-Myc inhibitor, and dichloroacetate (DCA), a PDK inhibitor, decreased the expression of glycolytic and serine synthetic enzymes in HCV-infected hepatocytes, resulting in suppressed viral replication. Furthermore, when co-administered with IFN-α or ribavirin, DCA further inhibited viral replication. In summary, HCV reprograms host cell metabolism to favor glycolysis and serine biosynthesis; this is mediated, at least in part, by increased PDK activity, which provides a surplus of nucleotide precursors. Therefore, blocking PDK activity might have therapeutic benefits against HCV replication.
- 29 July 2016
- Published by Springer Nature in Scientific Reports
- Vol. 6 (1) , 30846
Open AccessPyruvate dehydrogenase kinase regulates hepatitis C virus replication
During replication, hepatitis C virus (HCV) utilizes macromolecules produced by its host cell. This process requires host cellular metabolic reprogramming to favor elevated levels of aerobic glycolysis. Therefore, we evaluated whether pyruvate dehydrogenase kinase (PDK), a mitochondrial enzyme that promotes aerobic glycolysis, can regulate HCV replication. Levels of c-Myc, hypoxia-inducible factor-1α (HIF-1α), PDK1, PDK3, glucokinase, and serine biosynthetic enzymes were compared between HCV-infected and uninfected human liver and Huh-7.5 cells infected with or without HCV. Protein and mRNA expression of c-Myc, HIF-1α, and glycolytic enzymes were significantly higher in HCV-infected human liver and hepatocytes than in uninfected controls. This increase was accompanied by upregulation of serine biosynthetic enzymes, suggesting cellular metabolism was altered toward facilitated nucleotide synthesis essential for HCV replication. JQ1, a c-Myc inhibitor, and dichloroacetate (DCA), a PDK inhibitor, decreased the expression of glycolytic and serine synthetic enzymes in HCV-infected hepatocytes, resulting in suppressed viral replication. Furthermore, when co-administered with IFN-α or ribavirin, DCA further inhibited viral replication. In summary, HCV reprograms host cell metabolism to favor glycolysis and serine biosynthesis; this is mediated, at least in part, by increased PDK activity, which provides a surplus of nucleotide precursors. Therefore, blocking PDK activity might have therapeutic benefits against HCV replication.
- Open Access
- 15 May 2015
- Published by Wiley in Liver International
- Vol. 35 (10) , 2233-2245
Small heterodimer partner attenuates profibrogenic features of hepatitis C virus‐infected cells
Background & Aims: An atypical orphan nuclear receptor small heterodimer partner (SHP) is known to be regulated by AMP‐activated protein kinase (AMPK). Both of them inhibit TGF‐β and Smad signalling and exhibit antifibrotic activity in the liver. However, little is known about the protective effects of SHP and AMPK against hepatitis c virus (HCV)‐induced hepatic fibrosis.Methods: Levels of SHP, p‐AMPK and fibrotic markers in HCV‐infected human liver and in Huh‐7.5 cells infected with HCV genotype 2a (JFH‐1) were investigated. The effect of adenovirus‐mediated overexpression of SHP (Ad‐SHP) and AMPK activation via metformin and 5‐amino‐1‐b‐D‐ribofuranosyl‐imidazole‐4‐carboxamide (AICAR) on fibrotic gene expression was evaluated in HCV‐infected cells. Finally, we examined the effect of Ad‐SHP and AMPK activators on invasion and activation of LX2 human HSCs induced by conditioned media from HCV‐infected hepatocyte (CM).Results: In HCV‐infected human livers and Huh‐7.5 cells infected with HCV, SHP mRNA and protein levels were diminished compared with controls, whereas profibrotic factors were increased. Pharmacological AMPK activation recovered SHP expression, and Ad‐SHP inhibited HCV‐induced fibrotic gene expression. This finding was accompanied by inhibition of HCV‐stimulated nuclear factor‐kappa B, an inducer of TGF‐β. Moreover, CytoSelect invasion assay revealed that enhanced activity and invasiveness of hepatic stellate cells induced by CM.Conclusion: These results demonstrate that overexpression of SHP and activation of AMPK reverses profibrogenic features of HCV‐infected cells by decreasing TGF‐β and fibrotic gene expression. These findings provide a rationale for SHP as a possible therapeutic target against HCV‐induced hepatic fibrosis.
- 15 May 2015
- Published by Wiley in Liver International
- Vol. 35 (10) , 2233-2245
Open AccessSmall heterodimer partner attenuates profibrogenic features of hepatitis C virus‐infected cells
Background & Aims: An atypical orphan nuclear receptor small heterodimer partner (SHP) is known to be regulated by AMP‐activated protein kinase (AMPK). Both of them inhibit TGF‐β and Smad signalling and exhibit antifibrotic activity in the liver. However, little is known about the protective effects of SHP and AMPK against hepatitis c virus (HCV)‐induced hepatic fibrosis.Methods: Levels of SHP, p‐AMPK and fibrotic markers in HCV‐infected human liver and in Huh‐7.5 cells infected with HCV genotype 2a (JFH‐1) were investigated. The effect of adenovirus‐mediated overexpression of SHP (Ad‐SHP) and AMPK activation via metformin and 5‐amino‐1‐b‐D‐ribofuranosyl‐imidazole‐4‐carboxamide (AICAR) on fibrotic gene expression was evaluated in HCV‐infected cells. Finally, we examined the effect of Ad‐SHP and AMPK activators on invasion and activation of LX2 human HSCs induced by conditioned media from HCV‐infected hepatocyte (CM).Results: In HCV‐infected human livers and Huh‐7.5 cells infected with HCV, SHP mRNA and protein levels were diminished compared with controls, whereas profibrotic factors were increased. Pharmacological AMPK activation recovered SHP expression, and Ad‐SHP inhibited HCV‐induced fibrotic gene expression. This finding was accompanied by inhibition of HCV‐stimulated nuclear factor‐kappa B, an inducer of TGF‐β. Moreover, CytoSelect invasion assay revealed that enhanced activity and invasiveness of hepatic stellate cells induced by CM.Conclusion: These results demonstrate that overexpression of SHP and activation of AMPK reverses profibrogenic features of HCV‐infected cells by decreasing TGF‐β and fibrotic gene expression. These findings provide a rationale for SHP as a possible therapeutic target against HCV‐induced hepatic fibrosis.
- Open Access
- 1 January 2014
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in The Korean Journal of Pathology
- Vol. 48 (4) , 311-4
Undifferentiated Embryonal Sarcoma in Adult Liver
- 1 January 2014
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in The Korean Journal of Pathology
- Vol. 48 (4) , 311-4
Open AccessUndifferentiated Embryonal Sarcoma in Adult Liver
- Open Access
- 1 January 2013
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in The Korean Journal of Pathology
- Vol. 47 (5) , 486-488
A Primary Malignant Rhabdoid Tumor in Adult Liver
- 1 January 2013
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in The Korean Journal of Pathology
- Vol. 47 (5) , 486-488
Open AccessA Primary Malignant Rhabdoid Tumor in Adult Liver
- Open Access
- 1 January 2011
- Published by The Korean Surgical Society in Journal of the Korean Surgical Society
- Vol. 80 (4) , 297-300
Adrenal ganglioneuroma with hepatic metastasis
Jung HR, et al. J Korean Surg Soc. 2011 Apr;80(4):297-300. http://dx.doi.org/10.4174/jkss.2011.80.4.297
- 1 January 2011
- Published by The Korean Surgical Society in Journal of the Korean Surgical Society
- Vol. 80 (4) , 297-300
Open AccessAdrenal ganglioneuroma with hepatic metastasis
Jung HR, et al. J Korean Surg Soc. 2011 Apr;80(4):297-300. http://dx.doi.org/10.4174/jkss.2011.80.4.297
- Open Access
- 1 January 2010
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 42 (3) , 135-143
Clinicopathological and Immunohistochemical Features of Gastointestinal Stromal Tumors
The purpose of this study was to evaluate the clinicopathological features and immunohistochemical features of gastrointestinal stromal tumor (GIST), and specifically the expressions of platelet derived growth factor receptor A (PDGFRA), protein kinase C theta (PKC theta), discovered on GIST-1 (DOG-1), p16 and p27. Total 118 patients who underwent surgical resection for GIST at our institution between Jan 1997 and Dec 2007 were retrospectively studied. Immunohistochemical staining for c-kit, PDGFRA, PKC-theta, DOG-1, p16 and p27 was performed on a tissue microarray of the 118 GIST. The clinicopathologic parameters, the disease-free survival (DFS) and the overall survival rate were analyzed along with immunohistochemistry. The immunohistochemical stains for c-kit, CD34, PKC-theta, PDGFRA, DOG-1, p16 and p27 were positive in 89.8%, 72.0%, 56.8%, 94.9%, 90.7%, 69.5% and 44.1% of the tumor samples, respectively. The immunohistochemical expression of c-kit was strongly correlated with PKC-theta (p=0.000), DOG-1 (p=0.000) and CD34 (p=0.002). The DFS rate was significantly decreased for the patients with peritoneal GIST, high risk GIST, ≥10 cm-sized GIST, ≥10 mitoses/50 high power fields (HPFs) and p16 positivity (p=0.001, p=0.004, p=0.001, p=0.003 and p=0.028). GISTs ≥10 cm, epithelioid tumor cell type, and c-kit, and DOG-1 negativity were significantly associated with shorter period of overall survival (p=0.048, p=0.006, p=0.000 and p=0.000). The expression of p16 and no expression of c-kit and DOG-1 in GISTs, as well as peritoneal tumor site, high risk group, large tumor size, epithelioid tumor cell type and numerous mitoses, may be potentially prognostic factors for predicting worse outcome for patients who suffer from GIST.
- 1 January 2010
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 42 (3) , 135-143
Open AccessClinicopathological and Immunohistochemical Features of Gastointestinal Stromal Tumors
The purpose of this study was to evaluate the clinicopathological features and immunohistochemical features of gastrointestinal stromal tumor (GIST), and specifically the expressions of platelet derived growth factor receptor A (PDGFRA), protein kinase C theta (PKC theta), discovered on GIST-1 (DOG-1), p16 and p27. Total 118 patients who underwent surgical resection for GIST at our institution between Jan 1997 and Dec 2007 were retrospectively studied. Immunohistochemical staining for c-kit, PDGFRA, PKC-theta, DOG-1, p16 and p27 was performed on a tissue microarray of the 118 GIST. The clinicopathologic parameters, the disease-free survival (DFS) and the overall survival rate were analyzed along with immunohistochemistry. The immunohistochemical stains for c-kit, CD34, PKC-theta, PDGFRA, DOG-1, p16 and p27 were positive in 89.8%, 72.0%, 56.8%, 94.9%, 90.7%, 69.5% and 44.1% of the tumor samples, respectively. The immunohistochemical expression of c-kit was strongly correlated with PKC-theta (p=0.000), DOG-1 (p=0.000) and CD34 (p=0.002). The DFS rate was significantly decreased for the patients with peritoneal GIST, high risk GIST, ≥10 cm-sized GIST, ≥10 mitoses/50 high power fields (HPFs) and p16 positivity (p=0.001, p=0.004, p=0.001, p=0.003 and p=0.028). GISTs ≥10 cm, epithelioid tumor cell type, and c-kit, and DOG-1 negativity were significantly associated with shorter period of overall survival (p=0.048, p=0.006, p=0.000 and p=0.000). The expression of p16 and no expression of c-kit and DOG-1 in GISTs, as well as peritoneal tumor site, high risk group, large tumor size, epithelioid tumor cell type and numerous mitoses, may be potentially prognostic factors for predicting worse outcome for patients who suffer from GIST.